Trexquant Investment LP G1 Therapeutics, Inc. Transaction History

Trexquant Investment LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$5.19 - $13.5 $144,427 - $375,678	-27,828 Reduced 41.35%	39,465 $214,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $253,960 - $834,582	49,122 Added 270.33%	67,293 $840,000
Q2 2022 Aug 11, 2022	BUY	$4.04 - $8.51 $73,410 - $154,635	18,171 New	18,171 $90,000
Q1 2021 May 13, 2021	SELL	$17.58 - $32.59 $299,826 - $555,822	-17,055 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$10.99 - $20.4 $666,158 - $1.24 Million	-60,615 Reduced 78.04%	17,055 $307,000
Q3 2020 Nov 06, 2020	BUY	$11.55 - $23.75 $897,088 - $1.84 Million	77,670 New	77,670 $897,000
Q4 2019 Feb 12, 2020	SELL	$20.54 - $31.0 $196,115 - $295,988	-9,548 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$22.78 - $40.58 $217,503 - $387,457	9,548 New	9,548 $218,000
Q1 2019 May 13, 2019	SELL	$14.4 - $21.45 $144,777 - $215,658	-10,054 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$16.51 - $51.33 $53,723 - $167,027	-3,254 Reduced 24.45%	10,054 $193,000
Q3 2018 Nov 09, 2018	BUY	$43.15 - $67.97 $574,240 - $904,544	13,308 New	13,308 $696,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.